Citation Impact

Citing Papers

Mucosal healing in inflammatory bowel diseases: a systematic review
2012 Standout
Atypical hemolytic uremic syndrome
2011
From Pharmacokinetics to Pharmacogenomics: A New Approach to Tailor Immunosuppressive Therapy
2004
Validation of a Rapid and Sensitive Liquid Chromatography–Tandem Mass Spectrometry Method for Free and Total Mycophenolic Acid
2004
Immunosuppressive drug monitoring - what to use in clinical practice today to improve renal graft outcome
2005
Calcineurin Inhibitor Nephrotoxicity
2009 Standout
Pharmacogenomics and metabolite measurement for 6-mercaptopurine therapy in inflammatory bowel disease
2000 Standout
Non-Transgenic Mouse Models of Kidney Disease
2016 Standout
The cyclosporin PSC 833 increases survival and delays engraftment of human multidrug-resistant leukemia cells in xenotransplanted NOD-SCID mice
2002
The Role of Therapeutic Drug Monitoring in Individualizing Immunosuppressive Drug Therapy: Recent Developments
2006
Ulcerative Colitis Practice Guidelines in Adults (Update): American College of Gastroenterology, Practice Parameters Committee
2004 Standout
Complement Genes Strongly Predict Recurrence and Graft Outcome in Adult Renal Transplant Recipients with Atypical Hemolytic and Uremic Syndrome
2013
Modulating cell surface immunoreactivity by metabolic induction of unnatural carbohydrate antigens
2001 StandoutNobel
Identification of structures containing polyphosphate in Helicobacter pylori
1993
Validation of new methods
2006 Standout
Big data and machine learning algorithms for health-care delivery
2019 Standout
Advances in enhanced biological phosphorus removal: From micro to macro scale
2007 Standout
Targeting multidrug resistance in cancer
2006 Standout
Acute kidney injury
2019 Standout
Everolimus Versus Mycophenolate Mofetil De Novo After Lung Transplantation: A Prospective, Randomized, Open-Label Trial
2016
DAPI: a DNA-Specific Fluorescent Probe
1995
Calcineurin Inhibitor Avoidance with Daclizumab, Mycophenolate Mofetil, and Prednisolone in DR-Matched de Novo Kidney Transplant Recipients
2006
Use of Neoral C2 monitoring: a European consensus
2005
Inflammatory Bowel Disease
2002 Standout
Genotypic analysis of thiopurine S-methyltransferase in patients with Crohn's disease and severe myelosuppression during azathioprine therapy
2000
Clinical Pharmacokinetics and Pharmacodynamics of Tacrolimus in Solid Organ Transplantation
2004 Standout
Reduced Exposure to Calcineurin Inhibitors in Renal Transplantation
2007 Standout
Analysis of anticancer drugs: A review
2011 Standout
A Phase III Study of Belatacept‐based Immunosuppression Regimens versus Cyclosporine in Renal Transplant Recipients (BENEFIT Study)
2010 Standout
Cytochrome P450 2D6: overview and update on pharmacology, genetics, biochemistry
2004
The Third International Consensus Guidelines on the Management of Cytomegalovirus in Solid-organ Transplantation
2018 Standout
Biomarkers of Drug-Induced Kidney Toxicity
2018
Ciclosporin in psoriasis clinical practice: an international consensus statement
2004
New developments in the immunosuppressive drug monitoring of cyclosporine, tacrolimus, and azathioprine
2001
Thrombotic microangiopathy after kidney transplantation
2006
Lack of effect of intravenous administration on time to respond to azathioprine for steroid-treated Crohn's disease
1999
Azathioprine or methotrexate in the treatment of patients with steroid‐dependent or steroid‐resistant ulcerative colitis: results of an open‐label study on efficacy and tolerability in inducing and maintaining remission
2002
Should 6- Thioguanine Nucleotides Be Monitored in Heart Transplant Recipients Given Azathioprine?
1996
Cytochrome P450 enzymes in drug metabolism: Regulation of gene expression, enzyme activities, and impact of genetic variation
2013 Standout
The Use of Therapeutic Drug Monitoring to Optimise Immunosuppressive Therapy
1996
Bioluminescent sensor proteins for point-of-care therapeutic drug monitoring
2014 StandoutNobel
Immunosuppressive Drugs for Kidney Transplantation
2004 Standout
Infliximab, Azathioprine, or Combination Therapy for Crohn's Disease
2010 Standout
Immunotherapy in Elderly Transplant Recipients
2009
Management of Crohn's Disease in Adults
2009 Standout
Hypertension Following Kidney Transplantation
1994
In situ identification of polyphosphate‐ and polyhydroxyalkanoate‐accumulating traits for microbial populations in a biological phosphorus removal process
2001
Factors affecting operational tolerance after pediatric living-donor liver transplantation: impact of early post-transplant events and HLA match*
2011 StandoutNobel
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue
2019 Standout
Simultaneous determination of 6-thioguanine and methyl 6-mercaptopurine nucleotides of azathioprine in red blood cells by HPLC
1998
Contributions of hepatic and intestinal metabolism and P-glycoprotein to cyclosporine and tacrolimus oral drug delivery
1997
Luminescent Chemodosimeters for Bioimaging
2012 Standout
Inorganic polyphosphate is needed for swimming, swarming, and twitching motilities of Pseudomonas aeruginosa
2000 Standout
Infectious Diseases Society of America Guidelines for the Diagnosis and Treatment of Asymptomatic Bacteriuria in Adults
2005 Standout
Special Issue: KDIGO Clinical Practice Guideline for the Care of Kidney Transplant Recipients
2009 Standout
Drug Therapy in the Heart Transplant Recipient
2005
Individualizing liver transplant immunosuppression using a phenotypic personalized medicine platform
2016
Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America
2016 Standout
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
2016 Standout
Customized Mycophenolate Dosing Based on Measuring Inosine-Monophosphate Dehydrogenase Activity Significantly Improves Patients' Outcomes After Renal Transplantation
2010
Thiopurine Methyltransferase Genotype Predicts Therapy-Limiting Severe Toxicity from Azathioprine
1998
Endothelial Hypoxia-Inducible Factor-2α Is Required for the Maintenance of Airway Microvasculature
2019 StandoutNobel
Clinical practice guidelines for managing dyslipidemias in kidney transplant patients: a report from the Managing Dyslipidemias in Chronic Kidney Disease Work Group of the National Kidney Foundation Kidney Disease Outcomes Quality Initiative
2004
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
2016 Standout
Pharmacogenomics: Translating Functional Genomics into Rational Therapeutics
1999 StandoutScience
A common rejection module (CRM) for acute rejection across multiple organs identifies novel therapeutics for organ transplantation
2013
Recommendations for the Outpatient Surveillance of Renal Transplant Recipients
2000
Measurement of thiopurine methyltransferase activity and azathioprine metabolites in patients with inflammatory bowel disease
2001

Works of Stein Bergan being referenced

Bilateral Pharmacokinetic Interaction Between Cyclosporine A and Atorvastatin in Renal Transplant Recipients
2001
Patterns of Azathioprine Metabolites in Neutrophils, Lymphocytes, Reticulocytes, and Erythrocytes
1997
Reduced Elimination of Cyclosporine A in Elderly (>65 Years) Kidney Transplant Recipients
2008
Cyclosporine A monitoring in patients with renal, cardiac, and liver transplants: A comparison between fluorescence polarization immunoassay and two different RIA methods
1993
Changes in polyphosphate composition and localization in Propionibacterium acnes after near-ultraviolet irradiation
1991
Kinetics of Mercaptopurine and Thioguanine Nucleotides in Renal Transplant Recipients During Azathioprine Treatment
1994
Automated Determination of Free Mycophenolic Acid and Its Glucuronide in Plasma From Renal Allograft Recipients
2003
Possibilities for Therapeutic Drug Monitoring of Azathioprine
1997
Lack of Effect of the Calcium Antagonist Isradipine on Cyclosporine Pharmacokinetics in Renal Transplant Patients
1991
MONITORED HIGH-DOSE AZATHIOPRINE TREATMENT REDUCES ACUTE REJECTION EPISODES AFTER RENAL TRANSPLANTATION
1998
Cyclosporine C2 Levels Have Impact on Incidence of Rejection in De Novo Lung but Not Heart Transplant Recipients: The NOCTURNE Study
2009
Cinacalcet's effect on the pharmacokinetics of tacrolimus, cyclosporine and mycophenolate in renal transplant recipients
2007
C2 monitoring in maintenance renal transplant recipients: is it worthwhile?
2003
Pharmacodynamics of Mycophenolic Acid in CD4+ Cells: A Single-Dose Study of IMPDH and Purine Nucleotide Responses in Healthy Individuals
2008
Barcelona Consensus on Biomarker-Based Immunosuppressive Drugs Management in Solid Organ Transplantation
2016
MONITORING OF AZATHIOPRINE TREATMENT BY DETERMINATION OF 6-THIOGUANINE NUCLEOTIDE CONCENTRATIONS IN ERYTHROCYTES1
1994
MONITORING OF AZATHIOPRINE TREATMENT BY DETERMINATION OF 6-THIOGUANINE NUCLEOTIDE CONCENTRATIONS IN ERYTHROCYTES1
1994
Calcineurin Inhibitor-Free Immunosuppression in Renal Allograft Recipients with Thrombotic Microangiopathy/Hemolytic Uremic Syndrome
2006
Improved prediction of tacrolimus concentrations early after kidney transplantation using theory‐based pharmacokinetic modelling
2014
Pharmacokinetics of diltiazem and its metabolites in relation to CYP2D6 genotype
2002
Rankless by CCL
2026